Review of Autism Spectrum Disorder (ASD): Epidemiology, Aetiology, Pathology, and Pharmacological Treatment
Pharmaceuticals · 30.10.2025 · 18 (11) · 1644
DOI: 10.3390/ph18111644 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 30.10.2025. Verfasst von Mashal Aljead und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Birmingham, University of Birmingham Open Access Fund.
Abstract (Originalsprache)
Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by challenges in social and communication skills and restricted interests. It is associated with behavioural symptoms and/or comorbidities (e.g., attention deficit hyperactivity disorder (ADHD)). Developing effective treatments for ASD remains a challenge because its pathophysiology is not fully understood. Multiple treatment options are used for ASD with varying levels of effectiveness and safety profiles. Atypical antipsychotics (AAPs), particularly risperidone and aripiprazole, provide superiority over other drug classes of pharmacological interventions. However, they are linked to adverse drug reactions (ADRs), specifically metabolic and endocrine ADRs. These ADRs may lead to chronic diseases such as diabetes and cardiovascular conditions, adding strain to healthcare systems beyond the original treatment of ASD. This narrative review enhances our understanding of ASD and highlights a gap in current knowledge about the evaluation of the effectiveness and safety of pharmacological treatments, especially AAPs for ASD in paediatric patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
- Psychiatry Services, Brooklands Hospital, Coventry and Warwickshire Partnership NHS Trust, Birmingham B37 7HH, UK.
ORCID-Profile: Zahraa Jalal, Alan M Jones
Förderung
- University of Birmingham
- University of Birmingham Open Access Fund
Zitieren
APA
Aljead, M., Qashta, A., Jalal, Z., & Jones, A. M. (2025). Review of Autism Spectrum Disorder (ASD): Epidemiology, Aetiology, Pathology, and Pharmacological Treatment. Pharmaceuticals, 18(11), 1644. https://doi.org/10.3390/ph18111644
Vancouver
Aljead M, Qashta A, Jalal Z, Jones AM. Review of Autism Spectrum Disorder (ASD): Epidemiology, Aetiology, Pathology, and Pharmacological Treatment. Pharmaceuticals. 2025;18(11):1644. doi:10.3390/ph18111644
BibTeX
@article{Aljead2025,
author = {Aljead, Mashal and Qashta, Aya and Jalal, Zahraa and Jones, Alan M},
title = {Review of Autism Spectrum Disorder (ASD): Epidemiology, Aetiology, Pathology, and Pharmacological Treatment},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {11},
pages = {1644},
doi = {10.3390/ph18111644}
}
EUVIMED